| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/24/2003 | WO2003105855A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003105843A1 Methods of using isothiazole derivatives to treat cancer or inflammation |
| 12/24/2003 | WO2003105842A1 Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
| 12/24/2003 | WO2003105819A1 Quinone-type remedy for liver disease |
| 12/24/2003 | WO2003105818A1 Quinone-based remedies for liver diseases |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105769A2 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| 12/24/2003 | WO2003089593A3 Adjuvant enhanced immunotherapy |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation |
| 12/24/2003 | WO2003083113A3 Growth regulating proteins |
| 12/24/2003 | WO2003079020A3 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer |
| 12/24/2003 | WO2003078458A3 Tap-70, a novel marker for epithelial tumors |
| 12/24/2003 | WO2003078455A3 Virus like particle from papillomavirus and their use in vaccine |
| 12/24/2003 | WO2003077942A3 Virus-like particles of human papillomavirus |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/24/2003 | WO2003074529A3 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS |
| 12/24/2003 | WO2003072768A3 Modified human manganese superoxide dismutase and uses thereof |
| 12/24/2003 | WO2003072050A3 Prevention of and therapy for radiation toxicity of normal tissues using drugs which block il-1 activity |
| 12/24/2003 | WO2003070914A3 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/24/2003 | WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
| 12/24/2003 | WO2003066806A3 Therapeutic use of aziridino compounds |
| 12/24/2003 | WO2003066659A3 Improved method for obtaining betulinic acid |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 12/24/2003 | WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 12/24/2003 | WO2003055917A3 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 12/24/2003 | WO2003050251A3 Hematopoietic cells from human embryonic stem cells |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003045429A3 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 12/24/2003 | WO2003040294A3 METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs |
| 12/24/2003 | WO2003038095A3 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 12/24/2003 | WO2003037886A3 Heteroaromatic carboxamide derivatives for the treatment of inflammation |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003035137A3 Method and apparatus for dispensing inhalator medicament |
| 12/24/2003 | WO2003032900A3 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 12/24/2003 | WO2003028701A3 Liposomes containing (ether)lysolecithins |
| 12/24/2003 | WO2003027322A3 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 12/24/2003 | WO2003020280B1 Compositions and use thereof in the treatment of cancer |
| 12/24/2003 | WO2003011230A3 Modified reoviral therapy |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2003003985A8 Polyvalent conjugate vaccine for cancer |
| 12/24/2003 | WO2003000196A3 Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereof |
| 12/24/2003 | WO2003000113A3 Compositions and methods for the diagnosis and treatment of tumor |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002102825A3 Fluorescently labelled locked nucleic acids |
| 12/24/2003 | WO2002100858A8 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/24/2003 | WO2002096455A3 Use of polyclonal immunoglobulins |
| 12/24/2003 | WO2002088170A3 Cripto blocking antibodies and uses thereof |
| 12/24/2003 | WO2002087505A3 3-structure of a whole integrin $g(a)v$g(b)3 extracellular region and uses therefor |
| 12/24/2003 | WO2002081703A3 Mitogenic oxygenase regulators |
| 12/24/2003 | WO2002068548A8 Use of erss-selective ligands for regulating fertility and compounds useful therefore |
| 12/24/2003 | WO2002060483A3 Perylenequinones for use as photosensitizers and sonosensitizers |
| 12/24/2003 | WO2002047611A3 Cddo-compounds and combination therapies thereof |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | WO2002034204A8 Calcilytic compounds |
| 12/24/2003 | WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 12/24/2003 | WO2001092542A8 Integrin-targeting vectors having enhanced transfection activity |
| 12/24/2003 | CN1463270A Disulfide prodrugs and linkers and stablizers useful therefore |
| 12/24/2003 | CN1462755A Method for distilling active protein liquid of scorpion |
| 12/24/2003 | CN1462752A Chemotherapy medication-coupler of gem-bis phosphoric acid and synthetic method as well as usage |
| 12/24/2003 | CN1462749A Preparing anti-cancer active material in camptothecinum cell and method for restraining eancer cell |
| 12/24/2003 | CN1462629A Chinese herbal medicine for cooperation with chemotherapy for treating tumor and its preparation method |
| 12/24/2003 | CN1462617A Alkaloid oral applied drop pills possessing anticarcinogenesis and its preparation method |
| 12/24/2003 | CN1132012C Detection and treatment of cancer |
| 12/24/2003 | CN1131869C 新的含三(噁唑)的细胞毒性大环内酯化合物 New cytotoxic macrolide compounds containing tris (oxazole) of |
| 12/24/2003 | CN1131865C 作为选择性COX－2抑制剂的取代的咪唑并[1,2a]吖嗪 Substituted imidazole as selective COX-2 inhibitors and [1,2a] azines |
| 12/24/2003 | CN1131856C 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物 As cyclic thiocarbamate derivative of progesterone receptor modulators |
| 12/24/2003 | CA2489870A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | CA2489866A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | CA2489764A1 Method for detecting increased susceptibility to tumours |
| 12/24/2003 | CA2489726A1 Diagnosis and treatment of chemoresistant tumors |
| 12/24/2003 | CA2489648A1 Chemical process |
| 12/24/2003 | CA2489605A1 Oxaliplatin anti-resistance agent |
| 12/24/2003 | CA2489466A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | CA2489440A1 Anti-igf-i receptor antibody |
| 12/24/2003 | CA2489367A1 Compounds, compositions, and methods |
| 12/24/2003 | CA2489355A1 Methods of using isothiazole derivatives to treat cancer or inflammation |
| 12/24/2003 | CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation |
| 12/24/2003 | CA2489292A1 Vectors for expression of hml-2 polypeptides |
| 12/24/2003 | CA2489252A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| 12/24/2003 | CA2489245A1 Fluorinated cycloalkyl-derivatized benzoylguanidines and their use as a medicament |
| 12/24/2003 | CA2489214A1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 12/24/2003 | CA2489182A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 12/24/2003 | CA2489004A1 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | CA2488880A1 Quinone-based therapeutic agent for hepatopathy |
| 12/24/2003 | CA2488879A1 Compositions for the transport of therapeutic molecules into the lungs and use thereof for the treatment of lung cancers and pulmonary diseases |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |
| 12/24/2003 | CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 12/24/2003 | CA2488117A1 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | CA2487948A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | CA2487809A1 Aptamer-toxin molecules and methods for using same |
| 12/24/2003 | CA2486649A1 Fusion protein comprising angiopoietin receptor-binding and a multimerization domain |
| 12/24/2003 | CA2486215A1 Mitotic kinesin inhibitors |
| 12/24/2003 | CA2485346A1 Human adam-10 inhibitors |
| 12/24/2003 | CA2479309A1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |